BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2017
View Archived Issues
AmorChem Holdings spins out two new companies
Read More
Silence Therapeutics acquires equity stake in Arrowhead Pharmaceuticals
Read More
Allergan licenses rights to Assembly Biosciences' microbiome programs
Read More
FDA accepts Adaptimmune's IND for T-cell therapy targeting MAGE-A4
Read More
Vescor formed to develop autophagy therapeutics
Read More
FASN inhibitors reported in Teva patent
Read More
Chongqing University reports PDE5A inhibitors
Read More
NeuroVive, Karolinska Institutet enter collaboration for cyclophilin inhibitor
Read More
Moderna Therapeutics: developing mRNA therapeutics
Read More
Lumason obtains FDA approval for the use in ultrasonography
Read More
Servier and Vernalis jointly patent Mcl-1 inhibitors
Read More
Shionogi's cefiderocol shows positive results in cUTI study
Read More
Novartis to conduct phase II study of bimagrumab
Read More
EC approves Novo Nordisk's Fiasp for diabetes
Read More
Amgen and Immatics Biotechnologies collaborate on novel bispecific cancer immunotherapies
Read More
Bayer describes BUB1 inhibitors for cancer
Read More
Wockhardt reports antibacterial activity enhancers
Read More
Tasly Pharmaceutical describes platelet aggregation inhibitors
Read More
Crinetics Pharmaceuticals presents somatostatin receptor agonists
Read More
Update on clinical trials of dendritic cell vaccine TLP0-001
Read More
Takara Bio applies to conduct Japanese phase I/II study of CAR therapy
Read More
Protein Sciences Zika vaccine shows good safety results in preclinical studies
Read More
Phase I results from ZUMA-1 trial of KTE-C19 in patients with refractory DLBCL
Read More
MedImmune initiates phase I/Ib study of MEDI-3726 in metastatic castration-resistant prostate cancer
Read More
CRISPR Cas9 gene repair strategy shows promise for treatment of X-CGD
Read More
ViraCyte's T-cell immunotherapy wins FDA fast track, orphan designations
Read More
Heron Therapeutics submits NDA for Cinvanti in U.S.
Read More
Phase I trial explores MK-7684 alone and in combination with pembolizumab in advanced solid tumors
Read More